Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Ronnie W. Miller, Hoffmann-La Roche Limited
Al Reba, Bristol-Myers Squibb Canada
Jared Rhines, Akcea Therapeutics Canada Inc.
Jorge Bartolome, Janssen Inc.
Ed Dybka, Ipsen Biopharmaceuticals Canada, Inc.
Frédéric Fasano, Servier Canada Inc.
John Haslam, Horizon Therapeutics Canada Inc.
Brian Heath, Amgen Canada Inc.
Alok Kanti, Bayer Inc.
Michael Mullette, Sanofi Canada
Cole Pinnow, Pfizer Canada ULC
Anna van Acker, Merck Canada Inc.